(Q48222467)

9 February 2018

title

In vivo and in vitro activity of roxithromycin against Toxoplasma gondii in mice (English)

1 reference

9 February 2018

0 references

B J Luft

1

1 reference

9 February 2018

publication date

1 August 1987

1 reference

9 February 2018

European journal of clinical microbiology

published in

1 reference

9 February 2018

volume

6

1 reference

9 February 2018

issue

4

1 reference

9 February 2018

page(s)

479-481

1 reference

9 February 2018

In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02013115

Activity of roxithromycin (RU 28965), a macrolide, against Toxoplasma gondii infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013115

Effect of clindamycin on acute and chronic toxoplasmosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013115

Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013115

An evaluation of the curative effects of pyrimethamine and sulfadiazine, alone and in combination, on experimental mouse toxoplasmosis

21 January 2018

1 reference

12 December 2020

New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A.

1 reference

12 December 2020

The adverse effect of pregnancy on macrophage activation

1 reference

12 December 2020

Demonstration of T-cell dysfunction during acute toxoplasma infection

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02013115

1 reference

9 February 2018

1 reference

9 February 2018